Back to top

Image: Bigstock

Top Ranked Growth Stocks to Buy for September 27th

Read MoreHide Full Article

Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, September 27th:

Asbury Automotive Group, Inc. (ABG - Free Report) : This auto dealership company which carries a Zacks Rank #1, has witnessed the Zacks Consensus Estimate for its current year earnings increasing 1.8% over the last 60 days.

Asbury Automotive Group has a PEG ratio of 0.76 compared with 4 for the industry. The company possesses a Growth Scoreof A.

Funko, Inc. (FNKO - Free Report) : This toy company, which carries a Zacks Rank #1 (Strong Buy), has witnessed the Zacks Consensus Estimate for its current year earnings increasing 6.1% over the last 60 days.

Funko, Inc. Price and Consensus

Funko, Inc. Price and Consensus

Funko, Inc. price-consensus-chart | Funko, Inc. Quote

Funko has a PEG ratio of 0.8, compared with 1.19 for the industry. The company possesses a Growth Score of B.

Funko, Inc. PEG Ratio (TTM)

Funko, Inc. PEG Ratio (TTM)

Funko, Inc. peg-ratio-ttm | Funko, Inc. Quote

AngloGold Ashanti Limited (AU - Free Report) : This mining company, which carries a Zacks Rank #1, has witnessed the Zacks Consensus Estimate for its current year earnings increasing 20.5% over the last 60 days.

AngloGold Ashanti has a PEG ratio of 0.42, compared with 1.41 for the industry. The company possesses a Growth Score of B.

BrightView Holdings, Inc. (BV - Free Report) : This landscaping services company, which carries a Zacks Rank #2 (Buy), has witnessed the Zacks Consensus Estimate for its current year earnings increasing 4.6% over the last 60 days.

BrightView has a PEG ratio of 0.8, compared with 13.73 for the industry. The company possesses a Growth Score of A.

See the full list of top ranked stocks here.

Learn more about the Growth score and how it is calculated here.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>